Drug Type Peptide drug conjugates |
Synonyms Analogues 60 |
Target |
Mechanism EWS-FLI1 inhibitors(EWS-FLI1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ewing Sarcoma | Preclinical | US | 13 Sep 2018 |